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Abstract
The axial and appendicular skeleton of vertebrates develops by endochondral ossification, in which skeletogenic tissue is
initially cartilaginous and the differentiation of chondrocytes via the hypertrophic pathway precedes the differentiation of
osteoblasts and the deposition of a definitive bone matrix. Results from both loss-of-function and misexpression studies
have implicated the related homeobox genes Dlx5 and Dlx6 as partially redundant positive regulators of chondrocyte
hypertrophy. However, experimental perturbations of Dlx expression have either not been cell type specific or have been
done in the context of endogenous Dlx5 expression. Thus, it has not been possible to conclude whether the effects on
chondrocyte differentiation are cell autonomous or whether they are mediated by Dlx expression in adjacent tissues,
notably the perichondrium. To address this question we first engineered transgenic mice in which Dlx5 expression was
specifically restricted to immature and differentiating chondrocytes and not the perichondrium. Col2a1-Dlx5 transgenic
embryos and neonates displayed accelerated chondrocyte hypertrophy and mineralization throughout the endochondral
skeleton. Furthermore, this transgene specifically rescued defects of chondrocyte differentiation characteristic of the Dlx5/6
null phenotype. Based on these results, we conclude that the role of Dlx5 in the hypertrophic pathway is cell autonomous.
We further conclude that Dlx5 and Dlx6 are functionally equivalent in the endochondral skeleton, in that the requirement for
Dlx5 and Dlx6 function during chondrocyte hypertrophy can be satisfied with Dlx5 alone.
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Introduction
The adult vertebrate skeleton appears to be a rather uniform bony
tissue. This apparent uniformity belies its embryonic origins, as a
mosaic structure originating from diverse progenitors that arise in
different germ layers, and its development via two distinct ontological
processes: intramembranous and endochondral ossification [1,2,3]. In
contrast to the direct differentiation of osteoblasts from mesenchymal
progenitors that produces the intramembranous bones of the skull and
clavicle, the caudal bones of the head, the vertebral column, ribs, and
appendicular skeleton develop first as cartilaginous anlagen [4].
Chondroblasts in these skeletal precursors have one of two fates: to
undergo a histologically well-defined program of hypertrophy and
terminal differentiation in the growing bone or to persist as specialized
chondrocytes at the articular surface [5,6]. The majority of
chondroblasts in prospective skeletal elements proliferate in regular
columns as radially flattened immature chondrocytes before maturing
through three distinct and spatially organized phases: prehypertrophic,
hypertrophic, and mineralizing chondrocytes. The hypertrophic
chondrocyte differentiation pathway is tightly regulated, with numer-
ous signalling pathways providing both positive and negative signals at
each step in the differentiation process. Some of these signals, like Ihh
and Delta, are made by subpopulations of differentiating chondrocytes
[7,8,9]. Others, like members of the TGF-b/BMP and Wnt families,
are also made by cells in the perichondrium [10,11,12], a tissue
that surrounds the growing cartilaginous core and gives rise to the
bone collar. Those competing extracellular signals induce or repress
transcription factors to regulate chondrocyte proliferation and
differentiation; the result is coordinated longitudinal bone growth
and joint articulation [6,13,14,15,16,17,18,19,20,21].
Dlx homeobox genes encode nuclear transcription factors
[22,23,24]. In particular, Dlx5 and Dlx6 are expressed in all anlagen
of the endochondral skeleton. Their expression has been noted in
precartilaginous limb bud mesenchyme [25,26] where each overlaps
with expression of Sox9 [27,28]. At later stages of skeletogenesis, when
proliferating and differentiating chondrocytes are found in spatially
distinct regions of the growth plate, Dlx5 and Dlx6 are expressed in
the post-mitotic prehypertrophic and hypertrophic zones but not in
immature chondroblasts in the resting or proliferating zones
[27,28,29]. Dlx5 and Dlx6 are also expressed in the perichondri-
um/periosteum in the long bones as well as ribs and vertebrae
[27,30,31,32]. Dlx5
2/2 and doubly deficient Dlx5/6
2/2 mice have
revealed requirements for Dlx5 and Dlx6 during chondrogenesis [28]
and chondrocyte hypertrophy [27,33]. Reciprocally, forced expres-
sion of either Dlx5 or Dlx6 alone in chicken limb bud micromass
cultures stimulated chondrogenesis [28] and misexpression of Dlx5 in
vivo reduced proliferation of epiphysial chondrocytes and resulted in
precocious chondrocyte hypertrophy [27,29,34]. Together, these
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regulators of chondrocyte differentiation. However, to date, pertur-
bations of Dlx expression have either not been cell type specific or
have been done in the context of endogenous Dlx5 expression. This
general concern is particularly germane when seeking to elucidate a
cell-autonomous function for Dlx5 in chondrocyte hypertrophy given
endogenous Dlx5 expression in both the differentiating chondrocytes
and in the perichondrium, the site of synthesis of secreted factors that
regulate this process in the chondrogenic core. Here, we first describe
a transgenic line of mice in which exogenous Dlx5 expression is
targeted to immature chondrocytes using regulatory elements from
the Col2a1 gene. Tissue-specific misexpression of Dlx5 accelerated
chondrocyte hypertrophy and promoted precocious ossification in
the endochondral skeleton of these transgenic mice. Visualization of
transgene expression in the absence of endogenous Dlx5 expression
(achieved by crossing the allele onto a Dlx5/6 null background)
indicated that transgene expression was limited to the chondrogenic
core and not the perichondrium. The subsequent rescue of
endochondral ossification defects in Dlx5/6
2/2;C o l 2 a 1 - D l x 5mice
therefore establishes a cell-autonomous function for Dlx5 during
chondrocyte hypertrophy and, furthermore, demonstrates functional
equivalence of Dlx5 and Dlx6 in the endochondral skeleton.
Results
Generation of Transgenic Mice and Characterization of
Transgene Expression
Dlx5 and its cis-linked paralogue Dlx6 function as positive
regulators of both chondrogenesis and chondrocyte hypertrophy
in the endochondral skeleton [27,28,29,33]. To further investigate
the function of Dlx5 during chondrocyte hypertrophy in vivo,w e
generated transgenic mice in which a Dlx5 cDNA was expressed
under control of the promoter and intron 1 enhancer of the Col2a1
gene (Fig. 1A) so as to target Dlx5 expression to immature
chondrocytes following their differentiation from pluripotent
mesenchymal precursors. Following pro-nuclear injection, we
obtained four Col2a1-Dlx5 transgenic founders; these four founders
(or their hemizygous offspring) had a variable number of copies of
the transgene, as measured by semi-quantitative PCR from
genomic DNA (Fig. 1B). The three founders with the highest
number of copies (more than ten) were recovered dead as neonates
and their transgenic alleles are referred to as Col2a1-Dlx5
t1, Col2a1-
Dlx5
t2, and Col2a1-Dlx5
t3. The viable founder with allele Col2a1-
Dlx5
t19 had fewer than four copies as a hemizygote and was used
to establish a stable transgenic line expressing epitope-tagged Dlx5
(Fig. 1C).
To examine the tissue distribution of transgene expression, we
examined embryos following whole mount in situ hybridization
with a Dlx5 riboprobe. Dlx5 expression was visualized in a number
of locations that normally express the definitive chondroblast
marker Col2a1 (Fig. 2). In particular, and in contrast to non-
transgenic littermates, Dlx5 expression was apparent in somites
along the entire rostro-caudal axis and in rib cartilage and
throughout the skeletal anlagen of the limb, where it closely
matched expression of the endogenous Col2a1 gene in the stylopod
and zeugopod (Fig. 2A–E). In contrast, at E12.5 ectopic expression
of Dlx5 was most obvious in the phalanges, where it coincided with
endogenous Col2a1 expression. Endogenous expression of Dlx5 in
the otic vesicle, mandibular arch, branchial arches 2 and 3, or in a
proximal anterior mesodermal domain in the limb was not altered
Figure 1. Generation of Col2a1-Dlx5 transgenic mice. (A) Transgene design. Numbering of promoter and intron elements is with respect to the
Col2a1 transcription start site. The start codon of Col2a1 in exon 1 has been mutated to prevent translation in this exon [56]. The asterisk indicates the
Flag sequence 59 to the murine Dlx5 open reading frame, bpA, poly-adenylation sequence from the bovine Growth Hormone gene; SA, splice
acceptor. Half arrows indicate the approximate location of primers for genotyping: Col2a1 forward (Cf) plus Dlx5 reverse (Dr), and for RT-PCR: Flag
forward (Ff) plus Dr. (B) Transgene copy number. Semi-quantitative PCR was used to compare the approximate transgene copy number in transgenic
founder mice: t2/+ and t3/+ represent dead hemizygous founders and t19/+ is a hemizygote neonate from the stable Col2a1-Dlx5
t19/+ line. Control
lanes from the left are: wild type DNA (0), wild type DNA mixed with p3000i3020Col2a1-Dlx5 at 1 copy per genome equivalent (1) or 10 copies per
genome equivalent (10). Amplification of a genomic fragment of the single copy gene Ihh was used to judge relative amplification of the transgene.
(C) Specific amplification of expressed Flag-Dlx5 sequence from transgenic embryos in a reverse transcriptase-dependent manner. RT-PCR analysis of
five F4 generation embryonic day (E) 17.5 embryos from a wt x Col2a1-Dlx5
t19/+ mating demonstrates stable heritable expression of the Col2a1-Dlx5
transcription unit. The first lane in the bottom panel (+) shows a positive PCR control for the minus RT experiment. Non-adjacent lanes from the same
gel have been spliced together to generate the figure. Lane numbers refer to individual embryos.
doi:10.1371/journal.pone.0008097.g001
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ectopically in immature chondroblasts, we examined tissue
sections following in situ hybridization. Indeed, Dlx5 was expressed
throughout the Col2a1-expressing zones of the long bones and
vertebrae (Fig. 2F–I and data not shown), including the resting and
proliferating zones of the long bone epiphyses, where its expression
is not usually detectable (compare Fig 2H,I). Moreover, in the
hypertrophic zone, where Col2a1 transcription is normally down
regulated, we saw a parallel decrease in Flag-Dlx5 transcript
abundance (compare Fig. 2G,I). To view transcription of the
transgene in the absence of endogenous Dlx5 expression, we
introduced the Col2a1-Dlx5
t19 allele into a Dlx5/6
2/2 background.
Section in situ hybridization to the long bones of the limbs of Dlx5/
6
2/2; Col2a1-Dlx5
t19/+ embryos revealed that transgene expres-
sion was restricted to the cartilaginous core of the skeletal anlagen
and was not expressed in the surrounding perichondrium
(Fig. 2J,K). In summary, expression of the Col2a1-Dlx5
t19 allele
faithfully replicated endogenous Col2a1 gene expression in
chondrocytes and resulted in ectopic Dlx5 expression in immature
and proliferating chondroblasts.
Figure 2. Transgene expression in the endochondral skeleton. (A–E) Whole mount in situ hybridization of Dlx5 (A–C) or Col2a1 (D,E) probes to
wildtype(wt)andCol2a1-Dlx5
t19/+transgenic (t/+)littermatesatE11.5andE12.5.Arrows pointtosomitesinpanelA.Arrowheadpointstodigit2 inpanel
C. (F–I) Section in situ hybridization of Col2a1 (F,H) or Dlx5 (G,I) riboprobes to adjacent sections of the femur of wild type (F,G) or Col2a1-Dlx5
t19/+
transgenic embryos (H,I) at E14.5. Arrowheads indicate the Col2a1-positive proliferating zones, arrows point to the resting zones, and the bracket
demarcates the hypertrophic zone in panels G and I. Proximal is to the right. (J,K) Section in situ hybridization of Col2a1 (J) or Dlx5 (K) riboprobes to
adjacent sections of the tibia of Dlx5/6
2/2; Col2a1-Dlx5
t19/+ transgenic embryos at E14.5. Proximal is to the right. md, mandibular arch; ot, otic vesicle;
pam, proximal anterior mesoderm. Scale bar=1 mm in A, 0.5 mm in B–E,J,K, 0.2 mm in F–I.
doi:10.1371/journal.pone.0008097.g002
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Forced Expression of Dlx5 in Chondroblasts
To examine the functional consequencesof misexpressing Dlx5 in
chondrocytes, we first examined skeletal preparations of neonates at
postnatal day zero (P0) or P1 after staining cartilage and
mineralizing bone with alcian blue and alizarin red respectively.
All three dead founders, or viable neonates bearing the Col2a1-
Dlx5
t19 allele, examined this way had a common phenotype of
hypermineralization of the endochondral skeleton (Fig. 3). In its
most severe form, seen in three non-viable founders, hyperminer-
alization resulted inshorter stature (compare Fig.3A, B). The extent
of hypermineralization, as estimated from the extent of alizarin red
staining and generalized skeletaldysmorphology,followed theallelic
series Col2a1-Dlx5
t19/+ , Col2a1-Dlx5
t19/t19 , Col2a1-Dlx5
t2/+,
Col2a1-Dlx5
t3/+ , Col2a1-Dlx5
t1/+, and correlated with our
estimates of transgene copy number (Fig. 1B). We analyzed each
component of the skeleton in turn and uncovered a differential
sensitivity to transgene expression in the axial and appendicular
skeleton.
The basioccipital, exoccipital and supraoccipital bones of the
rostral skull arise from the most cranial somites [35]. Eventually,
the occipital bones fuse to surround the foramen magnum but the
mineralizing occipital bones of neonates are normally well
separated at birth, with alcian blue-staining cartilaginous matrix
between the supraoccipital and exoccipital bones and between the
exoccipital and basioccipital bones (Fig. 3C). Col2a1-Dlx5
t19/+
hemizygotes showed variable degrees of expanded mineralization
of the supra- and basioccipital bones at birth, such that these bones
sometimes touched or were fused at discrete points with the
adjacent edge of an exoccipital bone (Fig. 3D). The degree of
occipital ossification was scored for wild type (n=29) and t19/+
hemizygotes (n=35) at two developmental stages and is shown,
along with an explanation of the scoring system, in Fig. 3G. By P0,
all transgenic pups examined (n=24) showed some degree of
advanced ossification in the occipital bones, compared to 1 of 18
wild type neonates. In its most severe form, as exemplified by the
Col2a1-Dlx5
t1/+ founder, this hypermineralization was so excessive
that the supraoccipital and exoccipital bones were completely
fused, as were the first two cervical vertebrae and there was
hypermineralization in the chondrocranium surrounding the
interparietal bone (Fig. 3F). Indeed, the entire head was
dysmorphic in the recovered t1/+, t2/+, and t3/+ founders:
deeper dorso-ventrally but foreshortened rostro-caudally with
pronounced shortening of the maxillary process and dentary such
that the tongue protruded well past the jaws. Non-endochondral
components of the skull like the dentary and frontonasal bones
were likely to have been secondarily affected by accelerated
mineralization in the chondrocranium and were similarly affected
in all three dead founders (Fig. 3A,B and E,F).
The axial skeleton originates in the somitic sclerotome and
vertebrae with a diversity of shapes and functions subsequently
form along the rostral-caudal axis. Adjacent somites contribute to
single vertebral anlagen, which assemble from three sclerotomal
compartments: dorso-medial (dorsal neural arch and spinous
process), lateral (laminae and pedicles of the neural arch and ribs
at thoracic levels), and ventral (centrum and vertebral discs).
Embryonic vertebrae have discrete ossification centres in the
centrum and the neural arches, which normally fuse post-natally.
The vertebrae of P1 Col2a1-Dlx5
t19/+ hemizygous neonates (n=8)
showed precocious ossification between these centers in the form
of narrow bridges of mineralized tissue that joined the ossified
centrum and neural arch. This precocious ossification was further
advanced in Col2a1-Dlx5
t19/t19 homozygotes (n=9) such that the
majority of centra were completely fused to the adjacent neural
arches (Fig. 3H–J). The overall morphology of vertebrae and
length of the vertebral column were not strongly affected in this
line. While all vertebrae of the Col2a1-Dlx5
t1/+ founder were
completely fused, vertebrae were additionally dysmorphic and the
vertebral axis was significantly shorter in the strongest phenotypes
(Fig. 3K,L), resulting in the short stature of these founders
(Fig. 3A,B).
In contrast to the axial skeleton, the limbs of Col2a1-Dlx5 neonates
were mildly affected. Col2a1-Dlx5
t19/+ limbs were indistinguishable
from wild type in both overall size and in the extent of
mineralization. The limbs of homozygous Col2a1-Dlx5
t19/t19 neo-
nates averaged slightly smaller than wild type littermates (e.g. femurs
from homozygotes averaged 94% of wild type femur length, n=4,
Fig. 3M,N) but this wasnotstatistically significant.A limb phenotype
became more obvious in the most severely affected founder (Col2a1-
Dlx5
t1/+) in which the long bones were shorter and thicker than non-
transgenic controls, particularly in the hindlimb, and the relative
extent of mineralization was more advanced in the femur compared
to wild type controls (Fig. 3O,P). Finally, we did not observe truly
ectopic mineralization in cartilaginous structures that do not
normally ossify, like the trachea or chondrocostal cartilage. In
conclusion, our observations of the skeletons from four independent
Col2a1-Dlx5 alleles demonstrate that misexpression of Dlx5 in
immature chondrocytes promoted endochondral ossification in a
dose dependent manner and that, above a certain threshold, this
resulted in neonatal lethality.
We next asked whether the timing of onset of mineralization was
affected in Col2a1-Dlx5 embryos. At E14.5 there was no
mineralization in the centra of either wild type or transgenic
littermates, as visualized by alizarin red staining (not shown).
Thereafter, the initiation of mineralization in the centrum at a
specific axial level in wild type embryos was somewhat variable such
that, by E15.5, the number of vertebral centra in which
mineralization had commenced was quite disparate among
littermates of the same genotype, varying from zero to twelve
(Fig. 4A). While this variability continued through the next two days
of development, we reasoned that, if Dlx5 were affecting the onset of
mineralization, transgenic embryos would have consistently more
ossification centres in their vertebral centra at a given developmen-
talstage.Thiswas notthecase however (Fig.4A). Wealsomeasured
the proportion of the centrum that had mineralised at different
times to ask whether, once initiated, endochondral ossification was
accelerated. By E16.5, mineralization was well under way in all
thoracic and lumbar vertebrae in all embryos, regardless of
genotype. We found no difference in the extent of mineralization
at a given axiallevel at thisstage when comparingtransgenicorwild
type littermates (Fig. 4D). By E17.5 however, there was a clear
difference in the extent of ossification of the vertebral bodies in
Col2a1-Dlx5
t19/+ hemizygotes and additional areas of mineralization
were first apparent that bridged the mineralising region of the
centrum with mineralised tissue in the neural arches (Fig. 4B–F). In
contrast to hemizygotes at E17.5, when bridges were faintly
detectable in a variable number of vertebrae, all vertebrae from
the atlas to the fourth sacral vertebrae were affected in t19/t19
homozygotes and, moreover, the two mineralization centres were
completely fused (Fig. 4G). We also measured ossification of the ribs
and found a 10% difference in the extent of ossification of the ribs at
P0 (P,0.05, n=9 wild type, n=12 transgenic). However, no
significant difference in the extent of ossification in the long bones of
the limbs was apparent up to P0 (data not shown, n=20 wild type,
n=12 transgenic). Thus, expression of Dlx5 in somitic cartilage did
not appear to affect the initial timing of mineralization, but rather
contributed to a dose-dependent acceleration of ossification once
initiated.
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PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e8097Figure 3. Dose-dependent hypermineralization in the endochondral skeleton of Col2a1-Dlx5 transgenic neonates. (A,B) Lateral views
of a wild type CD-1 P0 pup (A) and two hemizygous Col2a1-Dlx5 transgenic pups (B), both found dead shortly after birth. (C,D) Dorsal view of the
caudal skull of wild type (C) and t19/+ (D) neonates at postnatal day zero (P0) following staining with alcian blue and alizarin red. The arrow points to
an area of fusion between the basioccipital and exoccipital bones in panel D. (E,F) Lateral views of a wild type (E) and t1/+ transgenic founder (F) at P0
after staining with alcian blue and alizarin red. (G) Bubble graph of the ossification index of multiple litters of t19/+ hemizygotes and their wild type
littermates. Following staining with alcian blue and alizarin red, a score was assigned to each embryo or neonate that reflected the extent of occipital
ossification relative to a typical wild type at that stage: 1=no brain case (exencephalic), 2=brain case intact but no ossification of the supraoccipital
(SO) apparent, 3=smaller SO than is seen in a majority of wild type specimens (which were assigned a score of 4); 5=obviously smaller distance
between the SO and exoccipital (EO), or between the EO and the basioccipital (BO), compared to a majority of wild type; 6=unilateral touching of SO
and EO or of EO and BO; 7=bilateral contact between SO and EO, or between the EO and the BO, or fusion of any of these bones. Bubble size is
proportional to the number of neonates with a given score; the smallest circles represent a single individual, the largest circle represents 17
individuals. (H–J) Ventral views of wild type (H), hemizygous (I) and homozygous (J) embryos with the Col2a1-Dlx5
t19 allele at P1 following alizarin red
staining. Arrowheads point to precociously mineralized vertebrae in panel I. (K,L) Ventral views of wild type (K), and Col2a1-Dlx5
t1/+ transgenic
founder (L) at P0 following alcian blue and alizarin red staining. The most caudal thoracic (T13) and sacral (S4) vertebrae are marked with white
asterisks. (M–P) Limb skeleton preparations from neonates with the genotypes as shown following alcian blue and alizarin red staining. at, atlas; at/
ax*, fused atlas and axis; ax, axis; BO, basioccipital; D, dentary, EO, exoccipital; fe, femur; fi, fibula; h, humerus; IP, interparietal; IP*, interparietal bone
with expanded mineralization; r, radius; sc, scapula; SO, supraoccipital; S/EO*, fused supraoccipital and exoccipital bones; t, tibia; u, ulna; wt, wild type.
Scale bar=5 mm in A,B, 1 mm in C,D, 2 mm in E,F,K–P, 0.5 mm in H–J.
doi:10.1371/journal.pone.0008097.g003
Dlx5 Acts Cell Autonomously
PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e8097We next sought to determine whether precocious mineralization
of the endochondral skeleton was due to an underlying acceleration
ofchondrocytedifferentiation.Weexaminedhematoxylinand eosin
stained sections through the head, trunk and limbs at various stages
(Fig. 5). At E16.5, before a mineralization phenotype was apparent
in the caudal skull, advanced hypertrophy of the basioccipital bone
was apparent. The lateral edges of the basioccipital bone contain
small, rounded chondroblasts in wild type embryos, whereas
hypertrophic chondrocytes occupied the entire element in trans-
genic littermates (Fig. 5A,B). Transverse sections through the
vertebrae of Col2a1-Dlx5
t19/+ transgenic neonates confirmed that
mineralization had occurred throughout the vertebrae, whereas the
ossification centres of the centrum and neural arches of wild type
pups were separated by blocks of cartilaginous tissue that contained
both radially flattened and hypertrophic chondrocytes (Fig. 5C,D).
Finally, we examined the growth plates of three-week-old mice after
H&E staining. There were no gross distortions in the overall
architecture of the growth plates of transgenic weanlings (n=3)
compared to wild type littermates (n=4), with both proliferating
and hypertrophic zones being of similar size, although dividing
chondrocytes in the proliferative zone were stacked somewhat less
regularly in transgenic mice (Fig. 5E,F). Thus, forced expression of
Dlx5 in immature chondrocytes resulted in accelerated chondrocyte
hypertrophy in the axial skeleton and a more subtle effect in the
growth plate of limbs.
To further confirm the basis of the phenotype, we examined the
expression of markers of prehypertrophic and hypertrophic
chondrocytes in transverse sections through the limbs and
vertebrae at times before an overt effect on mineralization was
apparent. Consistent with the idea that Dlx5 promoted precocious
ossification via accelerated chondrocyte hypertrophy, expression
of both prehypertrophic (Ihh) and hypertrophic (Col10a1) markers
was expanded in the limbs and vertebrae of Col2a1-Dlx5
t19/+
embryos compared with wild type littermates (Fig. 6). In summary,
expression of Dlx5 in immature chondrocytes promoted chondro-
cyte hypertrophy and endochondral ossification.
The Chondrocyte Hypertrophy Function of Dlx5 Is Cell
Autonomous and Is Sufficient to Rescue Endochondral
Ossification in Dlx5/6 Null Embryos
Dlx5 and Dlx6 have shared essential functions in mandibular
patterning and AER perdurance and Dlx5/6 null neonates are
exencephalic as a result of a failure to ossify the skull vault; in
particular, Dlx5/6 neonates lack supraoccipital and interparietal
bones at birth [33,36,37,38]. Targeted deletion of both Dlx5/6 also
revealed sharedfunctionsinthe endochondral skeleton. Defects that
arise as a result of delayed or absent chondrocyte differentiation
vary from the complete absence of mineralised endochondral
elements, notably the paired supraoccipital bones, to delayed
mineralization throughout the vertebral and appendicular skeleton
[33,36]. While the limb and axial skeleton of Dlx6
2/2 mice has not
yetbeendescribed,Dlx6islargelyredundantwithDlx5inpatterning
the first branchial arch [39]. Further understanding of the
functional equivalence of Dlx5 and Dlx6 in endochondral
Figure 4. The timing of the onset of mineralization in the vertebral bodies was not affected by Dlx5 but the subsequent rate of
ossification was. (A) Bubble graph depicting the number of vertebral centra in which mineralization was detectable after alcian blue and alizarin
red staining of wild type and t19/+ hemizygous embryos at three developmental stages. The smallest bubble represents a sample of one, the largest
represents eight individuals. (B,C) Dorsal view of the third and fourth lumbar vertebrae of a wild type and t19/+ hemizygote at E17.5 following alcian
blue and alizarin red staining. (D) Quantitation of the area of the L3 centrum that had mineralized, plotted as average area 6 sem. Wild type, white
bars (n=17 and n=18 at E16.5 and E17.5 respectively); Col2a1-Dlx5
t19/+, grey bars (n=4 and n=13 at E16.5 and E17.5 respectively); * P,0.005. (E–G)
Ventral views of wild type (E), hemizygous (F) and homozygous (G) embryos with the Col2a1-Dlx5
t19 allele at E17.5 following alizarin red staining.
Arrowheads point to precociously mineralizing vertebrae in panel F. Scale bar=0.5 mm for all photomicrographs.
doi:10.1371/journal.pone.0008097.g004
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context. We asked whether cartilage-specific expression of Dlx5
could rescue cartilage maturation defects in Dlx5/6 null embryos by
crossing Col2a1-Dlx5
t19 hemizygous mice (CD-1 background) with
heterozygous Dlx5/6
+/2 mice (C57Bl/6 x DBA background) to
specifically reconstitute Dlx5 function in the cartilage of otherwise
Dlx5/6 null embryos. Dlx5/6
2/2; Col2a1-Dlx5
t19/+ neonates
showed a rudiment of a mineralized element of varying size,
located dorsal to the exoccipital bones, which was interpreted to be
supraoccipital in identity (Fig. 7B, n=4), and partial rescue of the
supraoccipital was sometimes unilateral. In contrast, Dlx5/6
2/2;
Col2a1-Dlx5
t19/t19 homozygotes had mineralised supraoccipital
bones that were of a similar size to those in Dlx5/6
+/2 or wild type
littermates (Fig. 7C,D, n=3). Notably, the interparietal, which
forms via intramembranous ossification, was not rescued in these
animals, nor was transformation of mandibular structures to a
maxillary identity (Fig. 7). Finally, we asked whether rescue of
endochondral ossification was a general feature of these embryos by
examining a more quantitative trait, namely ossification of the
vertebral centra. Ossification of the centra of Dlx5/6 null embryos
lags that in wild type littermates, being, on average, 76% of that in
heterozygous or wild type littermates at E17.5 (Fig. 7E–H).
Vertebral mineralization in Dlx5/6
2/2; Col2a1-Dlx5
t19/+ embryos,
however, was indistinguishable from Dlx5/6
+/2 littermates. Taken
together, our data show that Dlx5 can fully compensate for Dlx6 in
the endochondral skeleton. While we cannot formally exclude the
possibility that Dlx5 was expressed at very low levels in the
perichondrium, that were below our detection limits, our results are
consistent with a cell autonomous function for Dlx5 during
chondrocyte hypertrophy.
Discussion
Dlx5 and Dlxt6 as Cell Autonomous Regulators of
Chondrocyte Hypertrophy
We have generated a line of transgenic mice in which the
transcription factor Dlx5 is expressed in proliferating chondro-
blasts. Interestingly, the level of expression of exogenous Dlx5 was
similar to that of endogenous Dlx5, as measured by in situ
hybridization, with both being expressed at much lower levels than
Col2a1. Our finding is consistent with the observations of others,
using essentially the same Col2a1 sequences [40] and likely reflects
the absence of cis-acting sequences that contribute to the higher
level expression of Col2a1. We consider this to be an advantage of
our mouse model since ectopic expression of Dlx5 is at near
physiological levels in Col2a1-Dlx5
t19 hemizygotes. Through cell type-
specific manipulation of its expression, we provide evidence that
Dlx5 is required cell autonomously for chondrocyte hypertrophy
and that Dlx6 has a redundant function in this tissue. This is best
demonstrated by the fact that restoration of Dlx5 expression in
Figure 5. Misexpression of Dlx5 in chondrocytes accelerated chondrocyte hypertrophy. (A,B) Haematoxylin and eosin (H&E) staining of
coronal sections of the head of wild type (A) and Col2a1-Dlx5 transgenic (B) E16.5 embryos. Arrows point to proliferating zones in panel A. Dorsal is
up. (C,D) Alizarin red-stained and cleared vertebral columns of wild type (C) and transgenic (D) P1 embryos were embedded in paraffin and sectioned.
Arrows point to cartilaginous tissue in panel C. Boxed region is shown at higher magnification in panel C insert. Dorsal is up. (E,F) H&E stained
longitudinal sections through the proximal humerus of wild type (E) and transgenic littermate (F). Proximal is up. Scale bar=0.2 mm in A,B,E,F, 2 mm
in C,D.
doi:10.1371/journal.pone.0008097.g005
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to rescue the supraoccipital bones in Dlx5/6-deficient mice.
Rescue of the supraoccipital bones in Dlx5/6
2/2; Col2a1-
Dlx5
t19/t19 neonates further indicates that chondrogenic differen-
tiation events prior to activation of Col2a1 are not defective in
Dlx5/6 null embryos but rather that the absence of the
supraoccipital bones in Dlx5/6
2/2 neonates is due to a subsequent
block in chondrocyte differentiation. This chondrogenic function
is apparently independent of the role of Dlx5 or Dlx6 as osteoblast
differentiation genes or as regulators of craniofacial patterning
since Dlx5/6
2/2; Col2a1-Dlx5
t19/t19 neonates retained intramem-
branous bone defects and transformation of mandibular to
maxillary structures. Similarly, Dlx5 likely has an independent
function in the perichondrium where it may promote differenti-
ation to the periosteum. Another study, in which Dlx5 was
specifically misexpressed in chondrocytes, documented enhanced
chondrocyte hypertrophy in the limb [34]. These tissue-specific
manipulations of Dlx5 expression validate the results of more
generalized over-expression studies with this gene [29].
Dlx6
2/2 mice display a range of first branchial arch defects
that closely resemble those seen in Dlx5
2/2 neonates, but that
are milder [39]. The non-additive nature of the patterning
defects that occur following the combined deletion of Dlx5 and
Dlx6 suggest functional redundancy of these genes in the first
branchial arch. Similarly, gain-of-function studies point to a
quantitatively equivalent function in stimulating multipotent
precursors to differentiate into chondroblasts [28]. The func-
tional equivalence of these genes in a specific tissue had not
previously been addressed in vivo; a definitive test of functional
equivalency requiring substitution of Dlx5 coding sequences for
those of Dlx6. This requirement is satisfied in embryos with
combined Col2a1-Dlx5
t19 and Dlx5/6
2/2 alleles and constitutes a
test of functional equivalency in cartilage. That both quantitative
and qualitative defects in endochondral ossification were rescued
by chondrocyte-specific expression of Dlx5 argues that Dlx5 and
Dlx6 are functionally interchangeable in chondrocytes and that
specific endochondral elements depend on different levels of
Dlx5 or Dlx6 activity; vertebral ossification was not completely
dependent on either Dlx5 or Dlx6 (since it was not completely
blocked in Dlx5/6 null embryos) and was rescued to wild type
levels in hemizygous Col2a1-Dlx5 embryos while complete rescue
of the supraoccipital bones required homozygosity of the
transgene in a Dlx5/6 null background. Nonetheless, it is quite
likely that some functions of the Dlx5-Dlx6 locus will depend on
diverged protein functions; some genes behave differently
following loss of Dlx6 versus Dlx5 in the mandibular arch, for
example [39]. This is not altogether surprising given the striking
differences in the amino acid sequences of the Dlx5 and Dlx6
proteins and the differential distribution of their transcriptional
activation activities [28].
Figure 6. Expansion of prehypertrophic and hypertrophic marker gene expression in Col2a1-Dlx5 transgenic mice. (A–D) In situ
hybridization of Ihh (A,C) or Col10a1 (B,D) riboprobes to adjacent cryosections of wild type and Col2a1-Dlx5 transgenic femurs at E14.5. Proximal is to
the right. (E–H) In situ hybridization of Ihh (E,G) or Col10a1 (F,H) riboprobes to adjacent cryosections of wild type and Col2a1-Dlx5 transgenic vertebral
centra at E16.5. Dorsal is up. Scale bar=0.2 mm for all photomicrographs.
doi:10.1371/journal.pone.0008097.g006
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PLoS ONE | www.plosone.org 8 November 2009 | Volume 4 | Issue 11 | e8097Figure 7. Chondrocyte-specific expression of Dlx5 rescued endochondral defects in Dlx5/6 null embryos. (A–D) Lateral views of the heads
of P0 neonates with the genotypes shown after staining with alcian blue and alizarin red. Asterisk indicates a missing supraoccipital bone in panel A.
Arrows point to supraoccipital bones in panels B–D. (E–G) Dorsal view of the second to fifth lumbar vertebrae from a Dlx5/6
2/2 (E), Dlx5/6
2/2; Col2a1-
Dlx5
t19/+(F),andDlx5/6
+/2 (G)embryoatE17.5followingalcianblueandalizarin redstaining. SinceDlx5/6
2/2 embryosaresmaller,digitalimages ofL2to
L5 at E17.5 were scaled to the same vertebral size to allow measurements of the relative mineralization of the vertebral bodies. Rostral is at the top. (H)
Quantitation of mineralization in the L3 centrum of Dlx5/6
2/2 (n=9), Dlx5/6
2/2; Col2a1-Dlx5
t19/+ (n=3), and Dlx5/6
+/2 (n=9) vertebrae, plotted as
average area 6 sem. * P,0.05; ns, P.0.05. Scale bar=2 mm in A–D, 0.5 mm in E,F,G.
doi:10.1371/journal.pone.0008097.g007
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Like Dlx5, Runx2 (encoding two isoforms that differ at their
amino-termini) is a multifunctional regulator of both chondrocyte
and osteoblast differentiation [41] and the two factors have some
remarkable parallels in both expression and function. Like Dlx5,
Runx2 is expressed in cartilaginous condensations and later, during
long bone growth, both genes are expressed in prehypertrophic
and hypertrophic chondrocytes. In addition, Dlx5 and Runx2 are
expressed in the perichondrium flanking the prehypertrophic and
hypertrophic zones and, in both cases, perichondrial expression
extends over the proliferating zone ([27,40,42,43,44,45,46,47] and
see Fig. 2H). As this study has demonstrated for Dlx5, either Runx2
isoform accelerated chondrocyte hypertrophy in the axial and
appendicular skeleton when misexpressed in immature cartilage
[40,48]. Isoform selective deletion further revealed that Runx2-II
has a non-redundant function in chondrocyte maturation [49] and
Runx2-II, rather than Runx2-I, is specifically expressed in
prehypertrophic and hypertrophic chondrocytes [47]. Runx2
isoforms also induced ectopic chondrocyte hypertrophy in
transgenic mice, in which persistent cartilage in the trachea and
chondrocostal cartilage was diverted to a hypertrophic fate
[40,48], and retroviral-mediated misexpression of Runx2-II
converted persistent cartilage to a hypertrophic fate in the chicken
hyoid skeleton [50]. In contrast, Dlx5 appears unable to induce
ectopic mineralization. None of our four Col2a1-Dlx5 alleles
caused ectopic mineralization in persistent cartilage. Even in
tissues that normally mineralise, Dlx5 misexpression did not
appear to affect the timing of the initial appearance of a calcified
matrix, but rather contributed to a subsequent acceleration once
begun. Indeed, in the vertebrae, the effects of an accelerated
deposition of calcified matrix in the centra were not apparent until
two days after mineralization was first visible. Similarly, we never
observed isolated patches of mineralized vertebral tissue between
the centrum and the neural arches; rather, premature minerali-
zation was always contiguous with the major ossifying zones of the
centrum and neural arches and their appearance coincided with
the first detectable Dlx5-mediated expansion of the mineralized
zones of centra at E17.5. Moreover, although prehypertrophic and
hypertrophic zones were expanded in transgenic mice, these zones
remained discrete and well defined. We did not observe, for
example, isolated cells or patches of cells that were either Ihh-o r
Col10a1-positive within the proliferative zone of limb bones. This
is in agreement with the observations of Chin et al. (7). In common
with Runx2 then, Dlx5 accelerates chondrocyte differentiation but,
in contrast, while Runx2 is capable of initiating chondrocyte
hypertrophy de novo, Dlx5 is unable to induce ectopic chondrocyte
hypertrophy in tissues where it would not normally occur, nor
advance the initial timing of mineralization. Thus, it is likely that
Dlx5 requires the synthesis of other rate-limiting critical cofactors
for its hypertrophic function. This is an interesting situation given
that Dlx5 appears to be a direct upstream regulator of Runx2
during osteoblast differentiation [51,52]. Nevertheless, our data
strongly suggest that Dlx5 is not sufficient for transactivation of
Runx2 in chondroblasts. Indeed, the signals and upstream
transcriptional regulators of Runx2 in chondrocytes are not yet
known.
The Mosaic Nature of the Skeleton
The differential sensitivity of the appendicular and axial
skeleton to a given level of ectopic Dlx5 expression is not without
precedent; non-uniform effects of Col2a1-driven transgenes in the
endochondral skeleton have been a hallmark of other studies too.
For example, the supraoccipital bone and vertebral skeleton was
more sensitive to the effects of a dominant negative PTHrP
receptor than the limbs, which only exhibited an effect at the
highest number of transgene copies and then only in discrete
elements [53]. Furthermore, expression of a constitutively active
form of Akt in immature chondrocytes led to accelerated
chondrocyte hypertrophy and mineralization in the cranial and
vertebral skeleton but delayed hypertrophy in limbs [54]. The
differential responses of the axial and appendicular skeleton to
Dlx5 and other regulators of cartilage development no doubt
reflects differences in the molecular milieu of anatomically distinct
chondrocytes and further underscores the mosaic nature of the
skeleton.
Materials and Methods
Ethics Statement
Prior institutional approval was received for the animal work
described in this study from the University of Guelph Animal Care
Committee, in accordance with Canadian Council on Animal
Care guidelines.
Generation of Transgenic Mice, Genotyping, and RT-PCR
The murine Dlx5 open reading frame was amplified as a 59 Flag-
tagged HindIII-NcoI fragment, and shuttled into a modified pSlax13
[55]. The bovine polyadenylation (bpA) sequence from
p3000i3020Col2a1 [56] was amplified and cloned downstream of
Dlx5 as an NcoI-XbaI fragment, and the FlagDlx5-bpA cassette was
cloned back into p3000i3020Col2a1 as a HindIII-SalIf r a g m e n t ,
replacing the bgeo-bpA sequences. The construct was digested with
NotIa n dSalI and the linear transgene cassette wasmicroinjected into
the pronuclei of fertilized CD-1 oocytes. Genotyping of transgene
bearing mice was done with forward primer 59-AACAGTTCCCC-
GAAAGAGGT-39 and reverse primer 59-GAGCGCTTTGCCA-
TAAGAAG-39, which amplified a 1040 bp fragment. The Col2a1-
Dlx5
t19 allele was maintained in a hemizygous state on a CD-1
background; hemizygous animals were occasionally bred to generate
homozygous embryos or neonates. Offspring from Col2a1-Dlx5
t19/+
x Dlx5/6
+/2 crosses were backcrossed to Dlx5/6 heterozygotes to
generate transgene-positive,Dlx5/6nullmice.A438 bpgenomicIhh
fragment was amplified with primers: 5-CACTTGTGGTGGAG-
GATGTG-39 and 59-TACCACACGCTTGTCAGCTC-39. Dlx5/
6 heterozygotes were genotyped with the lacZ primer pair: 59-
GCGTTACCCAACTTAATCG-39 and 59-TGTGAGCGAG-
TAACAACC-39 [32]. The presence of FlagDlx5 and b-actin mRNA
was determined on total RNA prepared from E16.5 embryos using
the Trizol Reagent (Invitrogen). 1 mgo fR N Aw a sr e v e r s e
transcribed (Superscript II, Invitrogen) and PCR amplified (Taq,
UBI Life Sciences) with standard protocols. Primer sequences used
for RT-PCR were: FlagDlx5 (For 59-GACTACAAGGACGAC-
GATGAC-39 and Rev 59-GAGCGCTTTGCCATAAGAAG-39)
andb-actin(For59-GAGAAAATCTGGCACCACACC-39;Re v5 9-
CAGGAAGGAAGGCTGGAAGAG-39).
Skeletal Staining
Alcian Blue and Alizarin Red staining was used to visualize
cartilaginous and mineralised skeletal tissues respectively of
embryos and neonates. Briefly, eviscerated and skinned
(.E16.5) bodies were fixed in 95% ethanol over several days.
Embryos were stained in 80% ethanol, 20% acetic acid, 0.01%
Alcian blue 8GX for 2–4 days, cleared overnight in 1% KOH,
stained 1–2 days in 0.001% Alizarin Red S in 1% KOH, then
rinsed in 1% KOH, and a graded series of H2O/glycerol to 100%
glycerol.
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Tissues were fixed overnight in 4% paraformaldehyde then
dehydrated and embedded in paraffin using standard techniques.
7 mm sections were stained with hematoxylin and eosin using a
standard protocol.
In Situ Hybridisation
Whole mount and cryosection in situ hybridisation was done as
described previously [55] with the following antisense riboprobes:
Dlx5, a 0.87 kb BamHI – HindIII fragment corresponding to the
full length open reading frame [28]; Col2a1, a 0.4 kb cDNA
corresponding to nt 1–402 of Genbank X57982; Ihh, a 1.8 kb
partial cDNA EcoRI fragment [57]; and Col10a1, a 0.86 kb ApaI-
SalI fragment containing nt 1351–2215 of Genbank X65121.
Imaging
Images were taken using a MicroPublisher colour digital camera
on a Leica MZ12.5 Stereomicroscope with Qcapture software
(QImaging) or on a Leica DMRA2 upright microscope with
Openlab software (Improvision) and processed using Adobe
Photoshop.
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